MedTrace Logo

Intranasal Ketorolac Tromethamine (SPRIX) as a Short Term Pain Management of Post-Vasectomy Pain

NCT02000388 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2013-12-04

No results posted yet for this study

Summary

To evaluate the efficacy, tolerability and safety of intranasal ketorolac tromethamine (SPRIX) as an option for pain management in post vasectomy patients.

Conditions

  • Post Vasectomy Pain

Interventions

DRUG

Ketorolac Tromethamine

OTHER

Standard of Care

Sponsors & Collaborators

  • Citrus Valley Medical Research, Inc.

    lead OTHER

Principal Investigators

  • Edward L Davis, M.D. · Citrus Valley Medical Research, Inc.

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
64 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2013-12-31
Completion
2013-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02000388 on ClinicalTrials.gov